Abiopharma

🔍 Byrd Richard (Executive)

Company: BECTON DICKINSON & CO (BDX)

Report Date: 2025-09-01

Detailed Transactions and Holdings:

• Sold 216 shares of Common Stock (Direct)
  Date: 2025-09-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 6,736.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units previously reported on Table 1.